ECSP045171A - Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia - Google Patents

Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia

Info

Publication number
ECSP045171A
ECSP045171A EC2004005171A ECSP045171A ECSP045171A EC SP045171 A ECSP045171 A EC SP045171A EC 2004005171 A EC2004005171 A EC 2004005171A EC SP045171 A ECSP045171 A EC SP045171A EC SP045171 A ECSP045171 A EC SP045171A
Authority
EC
Ecuador
Prior art keywords
concept
pharmaceutical composition
dosage regime
emergency anti
emergency
Prior art date
Application number
EC2004005171A
Other languages
English (en)
Spanish (es)
Inventor
Look Paul F A Van
Illesne Balgoh
Katalin Komandi
Laszlo Nemes
Zsolt Szabo
Original Assignee
Richter Gedeon Vegyeszet Gyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet Gyar Rt filed Critical Richter Gedeon Vegyeszet Gyar Rt
Publication of ECSP045171A publication Critical patent/ECSP045171A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
EC2004005171A 2001-11-27 2004-06-25 Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia ECSP045171A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel

Publications (1)

Publication Number Publication Date
ECSP045171A true ECSP045171A (es) 2004-08-27

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005171A ECSP045171A (es) 2001-11-27 2004-06-25 Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia

Country Status (33)

Country Link
US (1) US20050288264A2 (enExample)
EP (1) EP1448207B1 (enExample)
JP (1) JP2005516904A (enExample)
KR (1) KR100908161B1 (enExample)
CN (1) CN1551774A (enExample)
AP (1) AP1849A (enExample)
AT (1) ATE293978T1 (enExample)
AU (1) AU2002347401A1 (enExample)
BR (1) BR0210595A (enExample)
CA (1) CA2450359C (enExample)
DE (1) DE60203929T2 (enExample)
DK (1) DK1448207T3 (enExample)
EA (1) EA006545B1 (enExample)
EC (1) ECSP045171A (enExample)
ES (1) ES2239727T3 (enExample)
GE (1) GEP20063882B (enExample)
HR (1) HRP20040584B1 (enExample)
HU (1) HU227198B1 (enExample)
IL (1) IL159394A0 (enExample)
IS (1) IS2691B (enExample)
MA (1) MA27076A1 (enExample)
MX (1) MXPA04005104A (enExample)
NO (1) NO333984B1 (enExample)
NZ (1) NZ530056A (enExample)
OA (1) OA12730A (enExample)
PL (1) PL206010B1 (enExample)
PT (1) PT1448207E (enExample)
RS (1) RS50768B (enExample)
SI (1) SI1448207T1 (enExample)
TN (1) TNSN04048A1 (enExample)
UA (1) UA79942C2 (enExample)
WO (1) WO2003045397A1 (enExample)
ZA (1) ZA200404114B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EA201070715A1 (ru) * 2007-12-20 2011-02-28 Тева Вимен'С Хелс, Инк. Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
US9180131B2 (en) 2008-12-12 2015-11-10 Laboratoire Hra Pharma Method for contraception
RU2542779C2 (ru) 2009-04-14 2015-02-27 Лаборатуар Хра-Фарма Способ контрацепции, используемый по мере необходимости
BRPI1011815A2 (pt) 2009-06-23 2016-03-29 Bayer Pharma AG "composição farmacêutica para a contracepção de emergência"
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
MX342537B (es) 2011-06-01 2016-10-04 Estetra Sprl Proceso para la produccion de intermediarios de estetrol.
US11053274B2 (en) 2011-06-01 2021-07-06 Estetra S.P.R.L. Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
HRP20170797T1 (hr) * 2011-08-11 2017-08-11 Estetra S.P.R.L. Primjena estetrola kao hitnog kontraceptiva
AU2013349776A1 (en) 2012-11-22 2015-05-28 Bayer Pharma Aktiengesellschaft Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
KR20160014598A (ko) 2013-05-23 2016-02-11 바이엘 파마 악티엔게젤샤프트 제약 조성물 및 그의 용도, 및 필요시 피임을 위한 상기 제약 조성물의 적용 요법
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
EP3106148B1 (en) 2015-06-18 2018-03-14 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
HRP20200850T1 (hr) 2015-06-18 2020-10-02 Estetra Sprl Orodisperzibilna jedinica za doziranje koja sadrži komponentu estetrola
HUE054551T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Ösztetrolt tartalmazó, szájban diszpergálódó tabletta
JP6866561B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロールを含有する口腔内崩壊錠
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US20230338355A1 (en) * 2020-07-30 2023-10-26 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Also Published As

Publication number Publication date
DK1448207T3 (da) 2005-06-27
HU227198B1 (en) 2010-10-28
MXPA04005104A (es) 2004-08-19
HUP0105173A2 (hu) 2003-08-28
AP1849A (en) 2008-05-23
KR20040066088A (ko) 2004-07-23
NO333984B1 (no) 2013-11-04
AU2002347401A1 (en) 2003-06-10
EP1448207A1 (en) 2004-08-25
US20050288264A2 (en) 2005-12-29
ES2239727T3 (es) 2005-10-01
JP2005516904A (ja) 2005-06-09
AP2004003046A0 (en) 2004-06-30
NZ530056A (en) 2005-02-25
UA79942C2 (en) 2007-08-10
HUP0105173D0 (en) 2002-02-28
OA12730A (fr) 2006-06-28
CA2450359A1 (en) 2003-06-05
DE60203929D1 (de) 2005-06-02
KR100908161B1 (ko) 2009-07-16
PL369520A1 (en) 2005-04-18
IS7065A (is) 2003-12-05
PT1448207E (pt) 2005-08-31
IS2691B (is) 2010-10-15
EA006545B1 (ru) 2006-02-24
NO20041607L (no) 2004-04-20
GEP20063882B (en) 2006-07-25
HRP20040584A2 (en) 2005-02-28
CA2450359C (en) 2011-05-10
RS50768B (sr) 2010-08-31
US20050032755A1 (en) 2005-02-10
BR0210595A (pt) 2004-06-08
SI1448207T1 (en) 2005-10-31
HUP0105173A3 (en) 2004-03-29
EP1448207B1 (en) 2005-04-27
WO2003045397A1 (en) 2003-06-05
CN1551774A (zh) 2004-12-01
TNSN04048A1 (en) 2006-06-01
RS4204A (sr) 2007-02-05
IL159394A0 (en) 2004-06-01
PL206010B1 (pl) 2010-06-30
ATE293978T1 (de) 2005-05-15
DE60203929T2 (de) 2006-01-19
MA27076A1 (fr) 2004-12-20
ZA200404114B (en) 2005-10-26
HRP20040584B1 (en) 2012-11-30
EA200400731A1 (ru) 2004-12-30

Similar Documents

Publication Publication Date Title
ECSP045171A (es) Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
PT2336184E (pt) Administração de agentes para o tratamento da inflamação
FI20011478L (fi) Farmaseuttinen koostumus
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
GB0117618D0 (en) Pharmaceutical dosage form
NO20033384D0 (no) Farmasöytisk formulering
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
AR028317A1 (es) Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion
NO20033785L (no) Farmasöytisk formulering
GB0117619D0 (en) Pharmaceutical dosage form
NO20035627D0 (no) Farmasöytisk formulering
FI20022128A0 (fi) Farmaseuttinen koostumus
FI20000780L (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
GB0322848D0 (en) Tetracycline controlled release pharmaceutical dosage form
MXPA03009100A (es) Composicion farmaceutica y procedimiento de obtencion respectivo.
DE10107261B4 (de) Pharmazeutische Zusammensetzung
CL2004001263A1 (es) Composicion farmaceutica que comprende lamivudina, estavudina y efavirenzo, o derivados de ellos, kit farmaceutico; procedimiento para su preparacion; y uso en la preparacion de un medicamento para el tratamiento o prevencion de infecciones virales,
EP1413314A4 (en) MEDICAL COMPOSITIONS
DE60218683D1 (de) Pharmazeutische zusammensetzung für die nasale verabreichung von östradiol und norethisteron
NO20041236L (no) Farmasoytisk formulering